These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 10103176)
1. Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. Sudo K; Watanabe W; Konno K; Sato R; Kajiyashiki T; Shigeta S; Yokota T Antimicrob Agents Chemother; 1999 Apr; 43(4):752-7. PubMed ID: 10103176 [TBL] [Abstract][Full Text] [Related]
2. Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028). Sudo K; Konno K; Watanabe W; Shigeta S; Yokota T Microbiol Immunol; 2001; 45(7):531-7. PubMed ID: 11529559 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat. Sudo K; Yoshida K; Konno K; Ninomiya S; Hibino SM; Shigeta S; Yokota T Xenobiotica; 2002 Jan; 32(1):19-27. PubMed ID: 11820507 [TBL] [Abstract][Full Text] [Related]
4. Mouse model of respiratory syncytial virus infection to evaluate antiviral activity in vivo. Sudo K; Watanabe W; Mori S; Konno K; Shigeta S; Yokota T Antivir Chem Chemother; 1999 May; 10(3):135-9. PubMed ID: 10431613 [TBL] [Abstract][Full Text] [Related]
5. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model. Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300 [TBL] [Abstract][Full Text] [Related]
6. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines. Fuentes S; Arenas D; Moore MM; Golding H; Khurana S Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627 [TBL] [Abstract][Full Text] [Related]
7. Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo. Konno K; Miura M; Toriyama M; Motohashi S; Sawamura R; Watanabe W; Yoshida H; Kato M; Yamamoto R; Yasukawa K; Kurokawa M J Nat Med; 2013 Oct; 67(4):773-81. PubMed ID: 23344928 [TBL] [Abstract][Full Text] [Related]
8. Bivalirudin exerts antiviral activity against respiratory syncytial virus-induced lung infections in neonatal mice. Zhuang S; Tang Q; Chen P; Wang C; Liu G Acta Pharm; 2022 Sep; 72(3):415-425. PubMed ID: 36651544 [TBL] [Abstract][Full Text] [Related]
10. An immunocompromised BALB/c mouse model for respiratory syncytial virus infection. Kong X; Hellermann GR; Patton G; Kumar M; Behera A; Randall TS; Zhang J; Lockey RF; Mohapatra SS Virol J; 2005 Feb; 2():3. PubMed ID: 15701174 [TBL] [Abstract][Full Text] [Related]
11. Antiviral efficacy of VP14637 against respiratory syncytial virus in vitro and in cotton rats following delivery by small droplet aerosol. Wyde PR; Laquerre S; Chetty SN; Gilbert BE; Nitz TJ; Pevear DC Antiviral Res; 2005 Oct; 68(1):18-26. PubMed ID: 16112208 [TBL] [Abstract][Full Text] [Related]
12. Hydrogen Sulfide Is an Antiviral and Antiinflammatory Endogenous Gasotransmitter in the Airways. Role in Respiratory Syncytial Virus Infection. Ivanciuc T; Sbrana E; Ansar M; Bazhanov N; Szabo C; Casola A; Garofalo RP Am J Respir Cell Mol Biol; 2016 Nov; 55(5):684-696. PubMed ID: 27314446 [TBL] [Abstract][Full Text] [Related]
13. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy. Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294 [TBL] [Abstract][Full Text] [Related]
14. Direct Inhibition of Cellular Fatty Acid Synthase Impairs Replication of Respiratory Syncytial Virus and Other Respiratory Viruses. Ohol YM; Wang Z; Kemble G; Duke G PLoS One; 2015; 10(12):e0144648. PubMed ID: 26659560 [TBL] [Abstract][Full Text] [Related]
15. Recombinant superoxide dismutase (SOD) administered by aerosol inhibits respiratory syncytial virus infection in cotton rats. Wyde PR; Moore DK; Pimentel DM; Gilbert BE; Nimrod R; Panet A Antiviral Res; 1996 Jul; 31(3):173-84. PubMed ID: 8811202 [TBL] [Abstract][Full Text] [Related]
16. Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection. Cianci C; Genovesi EV; Lamb L; Medina I; Yang Z; Zadjura L; Yang H; D'Arienzo C; Sin N; Yu KL; Combrink K; Li Z; Colonno R; Meanwell N; Clark J; Krystal M Antimicrob Agents Chemother; 2004 Jul; 48(7):2448-54. PubMed ID: 15215093 [TBL] [Abstract][Full Text] [Related]
17. Post-infection A77-1726 blocks pathophysiologic sequelae of respiratory syncytial virus infection. Davis IC; Lazarowski ER; Chen FP; Hickman-Davis JM; Sullender WM; Matalon S Am J Respir Cell Mol Biol; 2007 Oct; 37(4):379-86. PubMed ID: 17541010 [TBL] [Abstract][Full Text] [Related]
18. Anti-Respiratory Syncytial Virus Activity of Chathuranga K; Kim MS; Lee HC; Kim TH; Kim JH; Gayan Chathuranga WA; Ekanayaka P; Wijerathne HMSM; Cho WK; Kim HI; Ma JY; Lee JS Viruses; 2019 Jul; 11(7):. PubMed ID: 31277257 [TBL] [Abstract][Full Text] [Related]
19. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model. Li L; Yu CH; Ying HZ; Yu JM J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991 [TBL] [Abstract][Full Text] [Related]
20. Aesculus hippocastanum L. seed extract shows virucidal and antiviral activities against respiratory syncytial virus (RSV) and reduces lung inflammation in vivo. Salinas FM; Vázquez L; Gentilini MV; O Donohoe A; Regueira E; Nabaes Jodar MS; Viegas M; Michelini FM; Hermida G; Alché LE; Bueno CA Antiviral Res; 2019 Apr; 164():1-11. PubMed ID: 30711418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]